| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.7 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |